A Monthly Dosed GLP-1 Analog for Treatment of Type 2 Diabetes Mellitus.

被引：0
|
作者：
Cleland, J. L. [1 ]
Geething, N. [2 ]
To, W. [2 ]
Spink, B. [2 ]
Lee, L. [2 ]
Yao, Y. [2 ]
Silverman, J. [2 ]
机构：
[1] Versartis Inc, Mountain View, CA USA
[2] Amunix Inc, Mountain View, CA USA
来源：
ENDOCRINE REVIEWS | 2010年 / 31卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Exenatide, a GLP-1 agonist in the treatment of Type 2 diabetes
    Sennik, Devesh
    Ahmed, Fahad
    Russell-Jones, David
    EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM, 2012, 7 (01) : 15 - 26
  • [32] GLP-1 gene delivery of type 2 for the treatment diabetes
    Oh, S
    Lee, M
    Ko, KS
    Choi, S
    Kim, SW
    MOLECULAR THERAPY, 2003, 7 (04) : 478 - 483
  • [33] Long acting GLP-1 for the treatment of type 2 diabetes
    Reichstetter, Sandra
    Castillo, Gerardo
    Perfetti, Riccardo
    Leahy, Mark
    Bolotin, Elijah
    DIABETES, 2007, 56 : A144 - A144
  • [34] GLP-1 analogues for treatment of type 2 diabetes in adolescents
    Veyder-Malberg, Caroline
    Furthner, Dieter
    Dalus, Christopher
    Maruszczak, Katharina
    Schneider, Anna-Maria
    Weghuber, Daniel
    MONATSSCHRIFT KINDERHEILKUNDE, 2021, 169 (03) : 253 - 257
  • [35] Role of GLP-1 induced glucagon suppression in type 2 diabetes mellitus
    Hare, Kristine Juul
    DANISH MEDICAL BULLETIN, 2010, 57 (09)
  • [36] GLP-1 receptor agonists and cirrhosis risk in type 2 diabetes mellitus
    Pavlicek, Vojtech
    DIABETOLOGIE, 2024, 20 (08): : 897 - 898
  • [37] Evaluating the Response to GLP-1 Agonists in Veterans with Type 2 Diabetes Mellitus
    Begley, Brett A.
    Desouza, Cyrus
    Shivaswamy, Vijay
    Samson, Kaeli
    Silverman, Emily
    DIABETES, 2021, 70
  • [38] Therapeutic approach of type 2 diabetes mellitus with GLP-1 based therapies
    Penfornis, A.
    Borot, S.
    Raccah, D.
    DIABETES & METABOLISM, 2008, 34 : S78 - S90
  • [39] The Effects of a GLP-1 Analog on Glucose Homeostasis in Type 2 Diabetes Mellitus Quantified by an Integrated Glucose Insulin Model
    Roge, R. M.
    Klim, S.
    Ingwersen, S. H.
    Kjellsson, M. C.
    Kristensen, N. R.
    CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY, 2015, 4 (01): : 28 - 36
  • [40] CJC-1131, a long acting GLP-1 analog for Type 2 diabetes mellitus: clinical development update
    Guivarch, PH
    Dreyfus, JF
    Mathi, S
    Castaigne, JP
    Drucker, DJ
    DIABETOLOGIA, 2004, 47 : A282 - A282
12345